Movatterモバイル変換


[0]ホーム

URL:


AU2001281463A1 - Chemoselective ligation - Google Patents

Chemoselective ligation

Info

Publication number
AU2001281463A1
AU2001281463A1AU2001281463AAU8146301AAU2001281463A1AU 2001281463 A1AU2001281463 A1AU 2001281463A1AU 2001281463 AAU2001281463 AAU 2001281463AAU 8146301 AAU8146301 AAU 8146301AAU 2001281463 A1AU2001281463 A1AU 2001281463A1
Authority
AU
Australia
Prior art keywords
phosphine
final product
amide bond
engineered
chemoselective ligation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001281463A
Inventor
Carolyn Bertozzi
Eliana Saxon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSDfiledCriticalUniversity of California Berkeley
Publication of AU2001281463A1publicationCriticalpatent/AU2001281463A1/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The present invention features a chemoselective ligation reaction that can be carried out under physiological conditions. In general, the invention involves condensation of a specifically engineered phosphine, which can provide for formation of an amide bond between the two reactive partners resulting in a final product comprising a phosphine moiety, or which can be engineered to comprise a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine byproduct and producing a native amide bond in the final product. The selectivity of the reaction and its compatibility with aqueous environments provides for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).
AU2001281463A2000-03-162001-03-16Chemoselective ligationAbandonedAU2001281463A1 (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US18983700P2000-03-162000-03-16
US60/1898372000-03-16
PCT/US2001/008546WO2001068565A2 (en)2000-03-162001-03-16Chemoselective ligation by use of a phosphine

Publications (1)

Publication NumberPublication Date
AU2001281463A1true AU2001281463A1 (en)2001-09-24

Family

ID=22698968

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU2001281463AAbandonedAU2001281463A1 (en)2000-03-162001-03-16Chemoselective ligation

Country Status (6)

CountryLink
US (7)US6570040B2 (en)
EP (1)EP1263771B1 (en)
AT (1)ATE329925T1 (en)
AU (1)AU2001281463A1 (en)
DE (1)DE60120650T2 (en)
WO (1)WO2001068565A2 (en)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6570040B2 (en)*2000-03-162003-05-27The Regents Of The University Of CaliforniaChemoselective ligation
CA2405105C (en)2000-05-122011-07-26Wisconsin Alumni Research FoundationLigation method and reagents to form an amide bond
US7256259B2 (en)2000-05-122007-08-14Wisconsin Alumni Research FoundationMethods for ligation of molecules to surfaces
US7173003B2 (en)*2001-10-102007-02-06Neose Technologies, Inc.Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en)2001-10-102007-05-08Neose Technologies, Inc.Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7795210B2 (en)*2001-10-102010-09-14Novo Nordisk A/SProtein remodeling methods and proteins/peptides produced by the methods
US8008252B2 (en)2001-10-102011-08-30Novo Nordisk A/SFactor VII: remodeling and glycoconjugation of Factor VII
US7157277B2 (en)2001-11-282007-01-02Neose Technologies, Inc.Factor VIII remodeling and glycoconjugation of Factor VIII
DE60313691T2 (en)2002-03-282007-10-18Unilever N.V. ice cream
US6974884B2 (en)2002-06-072005-12-13Wisconsin Alumni Research FoundationChemical synthesis of reagents for peptide coupling
DE60336555D1 (en)*2002-06-212011-05-12Novo Nordisk Healthcare Ag PEGYLATED GLYCO FORMS OF FACTOR VII
US20050233473A1 (en)*2002-08-162005-10-20Zyomyx, Inc.Methods and reagents for surface functionalization
ES2420581T3 (en)*2003-03-142013-08-26Biogenerix Gmbh Branched water soluble polymers and their conjugates
US20040235027A1 (en)*2003-03-312004-11-25Regent Of The University Of CaliforniaPreparation and application of ligand-biopolymer conjugates
US8791070B2 (en)2003-04-092014-07-29Novo Nordisk A/SGlycopegylated factor IX
EP2338333B1 (en)*2003-04-092017-09-06ratiopharm GmbHGlycopegylation methods and proteins/peptides produced by the methods
CA2524936A1 (en)*2003-05-092004-12-02Neose Technologies, Inc.Compositions and methods for the preparation of human growth hormone glycosylation mutants
US9005625B2 (en)*2003-07-252015-04-14Novo Nordisk A/SAntibody toxin conjugates
WO2005047245A2 (en)*2003-11-142005-05-26Wisconsin Alumni Research FoundationFluorescence assays with improved blocking groups
US7070941B2 (en)*2003-11-172006-07-04Board Of Regents, The University Of Texas SystemMethods and compositions for tagging via azido substrates
US8633157B2 (en)*2003-11-242014-01-21Novo Nordisk A/SGlycopegylated erythropoietin
US20080305992A1 (en)*2003-11-242008-12-11Neose Technologies, Inc.Glycopegylated erythropoietin
MXPA06005732A (en)*2003-11-242006-08-17Neose Technologies IncGlycopegylated erythropoietin.
US20060040856A1 (en)2003-12-032006-02-23Neose Technologies, Inc.Glycopegylated factor IX
US7956032B2 (en)2003-12-032011-06-07Novo Nordisk A/SGlycopegylated granulocyte colony stimulating factor
ES2422187T3 (en)*2003-12-032013-09-09Biogenerix Ag Glycopegylated granulocyte colony stimulating factor
ES2560657T3 (en)*2004-01-082016-02-22Ratiopharm Gmbh O-linked glycosylation of G-CSF peptides
WO2006010143A2 (en)2004-07-132006-01-26Neose Technologies, Inc.Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
WO2006020372A2 (en)*2004-07-232006-02-23Neose Technologies, Inc.Enzymatic modification of glycopeptides
WO2006021553A1 (en)*2004-08-232006-03-02Covalys Biosciences AgMethod for protein purification and labeling based on a chemoselective reaction
WO2006031811A2 (en)*2004-09-102006-03-23Neose Technologies, Inc.Glycopegylated interferon alpha
WO2006037095A2 (en)*2004-09-282006-04-06Baylor UniversitySpatially-defined modification of fresh tissue using covalent chemistry
CA2583389A1 (en)*2004-10-072006-04-20Emory UniversityMultifunctional nanoparticles conjugates and their use
JP2008515876A (en)*2004-10-072008-05-15コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Use of Staudinger ligation in imaging and therapy end kits for imaging and therapy
EP3061461A1 (en)*2004-10-292016-08-31ratiopharm GmbHRemodeling and glycopegylation of fibroblast growth factor (fgf)
EP2290369B1 (en)2004-12-222013-08-14California Institute Of TechnologyMethods for proteomic profiling using non-natural amino acids
WO2006074279A1 (en)*2005-01-062006-07-13Neose Technologies, Inc.Glycoconjugation using saccharyl fragments
MX2007008229A (en)*2005-01-102007-09-11Neose Technologies IncGlycopegylated granulocyte colony stimulating factor.
WO2006079364A1 (en)*2005-01-312006-08-03Stichting Voor De Technische WetenschappenSpecific and mild peptide or amide bond cleavage
US9187546B2 (en)2005-04-082015-11-17Novo Nordisk A/SCompositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
GB0507123D0 (en)*2005-04-082005-05-11Isis InnovationMethod
WO2006127910A2 (en)*2005-05-252006-11-30Neose Technologies, Inc.Glycopegylated erythropoietin formulations
US20110003744A1 (en)*2005-05-252011-01-06Novo Nordisk A/SGlycopegylated Erythropoietin Formulations
US20080255026A1 (en)*2005-05-252008-10-16Glycopegylated Factor 1XGlycopegylated Factor Ix
US20070105755A1 (en)2005-10-262007-05-10Neose Technologies, Inc.One pot desialylation and glycopegylation of therapeutic peptides
US20070134685A1 (en)*2005-09-062007-06-14Invitrogen CorporationControl of chemical modification
US20080267878A1 (en)*2005-10-042008-10-30Koninklijke Philips Electronics, N.V.Targeted Imaging And/Or Therapy Using The [3+2] Azide-Alkyne Cycloaddition
JP2009512642A (en)*2005-10-042009-03-26コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Staudinger reaction in imaging and therapy and kits used for imaging and therapy
US20100247433A1 (en)*2005-10-142010-09-30California Institute Of TechnologyUse of non-canonical amino acids as metabolic markers for rapidly-dividing cells
EP1937850B1 (en)2005-10-272019-05-29The President and Fellows of Harvard CollegeMethods and compositions for labeling nucleic acids
US20090048440A1 (en)2005-11-032009-02-19Neose Technologies, Inc.Nucleotide Sugar Purification Using Membranes
US7465544B2 (en)*2006-01-112008-12-16Wisconsin Alumni Research FoundationSynthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
US8114636B2 (en)2006-02-102012-02-14Life Technologies CorporationLabeling and detection of nucleic acids
DK3438131T3 (en)2006-02-102022-04-11Life Technologies Corp OLIGOSACCHARIDE MODIFICATION AND LABELING OF PROTEINS
DE602007007903D1 (en)*2006-02-212010-09-02Huntsman Int Llc METHOD OF MANUFACTURING A POLYISOCYANURATE COMPOUND
JP5885378B2 (en)*2006-03-222016-03-22ザ スクリプス リサーチ インスティテュート Preparation method of glycopeptide
JP2009531416A (en)*2006-03-282009-09-03コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Use of Staudinger ligation in in vivo assembly of bioactive compounds
WO2008011633A2 (en)*2006-07-212008-01-24Neose Technologies, Inc.Glycosylation of peptides via o-linked glycosylation sequences
US7985783B2 (en)2006-09-212011-07-26The Regents Of The University Of CaliforniaAldehyde tags, uses thereof in site-specific protein modification
EP2054521A4 (en)*2006-10-032012-12-19Novo Nordisk As METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES
WO2008060780A2 (en)*2006-10-042008-05-22Novo Nordisk A/SGlycerol linked pegylated sugars and glycopeptides
FI20075030A0 (en)*2007-01-182007-01-18Suomen Punainen Risti Veripalv Method of modifying cells
PL2144923T3 (en)*2007-04-032013-12-31Biogenerix AgMethods of treatment using glycopegylated g-csf
US20110177029A1 (en)*2007-06-042011-07-21Novo Nordisk A/SO-linked glycosylation using n-acetylglucosaminyl transferases
CN101778859B (en)*2007-06-122014-03-26诺和诺德公司Improved process for the production of nucleotide sugars
US7968811B2 (en)*2007-06-292011-06-28Harley-Davidson Motor Company Group, Inc.Integrated ignition and key switch
US8207112B2 (en)*2007-08-292012-06-26Biogenerix AgLiquid formulation of G-CSF conjugate
EP2242505A4 (en)*2008-01-082012-03-07Biogenerix AgGlycoconjugation of polypeptides using oligosaccharyltransferases
CA2715465C (en)2008-02-272017-03-21Novo Nordisk A/SConjugated factor viii molecules
US8034396B2 (en)*2008-04-012011-10-11Tyco Healthcare Group LpBioadhesive composition formed using click chemistry
US20110118142A1 (en)*2008-05-162011-05-19Life Technologies CorporationDual labeling methods for measuring cellular proliferation
US8350014B2 (en)*2008-11-172013-01-08Wisconsin Alumni Research FoundationPreparation of diazo and diazonium compounds
US9238878B2 (en)2009-02-172016-01-19Redwood Bioscience, Inc.Aldehyde-tagged protein-based drug carriers and methods of use
US8968733B2 (en)*2009-02-212015-03-03Sofradim ProductionFunctionalized surgical adhesives
US8956603B2 (en)2009-02-212015-02-17Sofradim ProductionAmphiphilic compounds and self-assembling compositions made therefrom
CA2753165A1 (en)2009-02-212010-08-26Sofradim ProductionCompounds and medical devices activated with solvophobic linkers
WO2010096649A1 (en)2009-02-212010-08-26Tyco Healthcare Group LpMedical devices having activated surfaces
US8968818B2 (en)2009-02-212015-03-03Covidien LpMedical devices having activated surfaces
EP2398584A2 (en)2009-02-212011-12-28Sofradim ProductionApparatus and method of reaching polymers by exposure to uv radiation to produce injectable medical devices
AU2010215196B2 (en)2009-02-212015-04-16Covidien LpCrosslinked fibers and method of making same by extrusion
US8512728B2 (en)2009-02-212013-08-20Sofradim ProductionMethod of forming a medical device on biological tissue
AU2010215202A1 (en)2009-02-212011-10-13Covidien LpCrosslinked fibers and method of making same using UV radiation
WO2010095056A2 (en)2009-02-212010-08-26Sofradim ProductionMedical devices with an activated coating
US8663689B2 (en)*2009-02-212014-03-04Sofradim ProductionFunctionalized adhesive medical gel
EP2398583B1 (en)2009-02-212020-12-23Sofradim ProductionApparatus and method of reacting polymers passing through metal ion matrix to produce injectable medical devices
US8535477B2 (en)*2009-02-212013-09-17Sofradim ProductionMedical devices incorporating functional adhesives
US8877170B2 (en)*2009-02-212014-11-04Sofradim ProductionMedical device with inflammatory response-reducing coating
DE102009012640A1 (en)2009-03-092010-09-30Freie Universität Berlin Phosphoamidate group modified compound and its use
WO2011045418A1 (en)*2009-10-162011-04-21Dsm Ip Assets B.V.Azido alkanoic acids and derivatives thereof in feed for reducing methane formation emanating from the digestive activities of ruminants
FR2952058B1 (en)2009-10-292013-10-04Centre Nat Rech Scient PROCESS FOR NATIVE LIGATION OF POLYPEPTIDES
EP2550034B1 (en)2010-03-252015-01-07Sofradim ProductionSurgical fasteners and methods for sealing wounds
CA2794335A1 (en)2010-03-252011-09-29Sofradim ProductionMedical devices incorporating functional adhesives
EP2588525A4 (en)2010-06-292015-06-10Covidien LpMicrowave-powered reactor and method for in situ forming implants
AU2011273102A1 (en)2010-07-012013-01-31Sofradim ProductionMedical device with predefined activated cellular integration
EP2598178B1 (en)2010-07-272018-07-11Sofradim ProductionPolymeric fibers having tissue reactive members
BR112013017980A2 (en)2011-01-142017-06-27Redwood Bioscience Inc aldehyde-labeled immunoglobulin polypeptides and method of use
FR2971509B1 (en)2011-02-162013-02-22Centre Nat Rech Scient PROCESS FOR PREPARING PEPTIDES BY ASSEMBLING MULTIPLE PEPTIDE FRAGMENTS
US20150072396A1 (en)2011-03-042015-03-12Life Technologies CorporationCompounds and Methods for Conjugation of Biomolecules
CN103534233B (en)2011-03-252016-08-24生命科技公司Heterobifunctional ester for labels targets molecule
US20140170653A1 (en)2011-04-152014-06-19Life Technologies CorporationChemical ligation
US9556195B2 (en)2011-09-122017-01-31The Regents Of The University Of CaliforniaCompositions and methods for quadricyclane modification of biomolecules
FR2981352B1 (en)2011-10-172015-07-03Centre Nat Rech Scient PROCESS FOR PROTEIN SYNTHESIS
FR2988392B1 (en)2012-03-212014-04-11Centre Nat Rech Scient NATIVE LIGATION METHOD
CN104704359A (en)2012-10-252015-06-10生命科技公司Methods and compositions for enzyme-mediated site-specific radiolabeling of glycoproteins
WO2014074218A1 (en)2012-11-122014-05-15Redwood Bioscience, Inc.Compounds and methods for producing a conjugate
US9775928B2 (en)2013-06-182017-10-03Covidien LpAdhesive barbed filament
US9493413B2 (en)2013-11-272016-11-15Redwood Bioscience, Inc.Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
DE102013113156A1 (en)*2013-11-282015-05-28Freie Universität Berlin A compound and method for selectively radiolabeling polypeptides by solid phase synthesis
US9410958B2 (en)2014-03-252016-08-09The Regents Of The University Of CaliforniaAlkyne-activated fluorogenic azide compounds and methods of use thereof
WO2017027337A1 (en)*2015-08-132017-02-16The Regents Of The University Of CaliforniaBioorthogonal reaction of an amine n-oxide and a boron agent
CN108463226B (en)2015-11-092022-04-15R.P.谢勒技术有限责任公司 Anti-CD22 antibody-maytansinoid conjugates and methods of using the same
US10195283B2 (en)2016-03-182019-02-05R.P. Scherer Technologies, LlcHydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate
CA3019398A1 (en)2016-04-262017-11-02R.P. Scherer Technologies, LlcAntibody conjugates and methods of making and using the same
EP3472210A1 (en)2016-06-172019-04-24Life Technologies CorporationSite-specific crosslinking of antibodies
US10814036B2 (en)2016-11-072020-10-27Baylor UniversityDrug-eluting live tissue for transplantation
WO2018136626A1 (en)2017-01-182018-07-26Visterra, Inc.Antibody molecule-drug conjugates and uses thereof
WO2018218004A1 (en)2017-05-242018-11-29The Board Of Regents Of The University Of Texas SystemLinkers for antibody drug conjugates
CA3113272A1 (en)2019-04-292020-11-05Illumina, Inc.Identification and analysis of microbial samples by rapid incubation and nucleic acid enrichment
EP4126064A1 (en)2020-04-032023-02-08Visterra, Inc.Antibody molecule-drug conjugates and uses thereof
EP4247829A1 (en)2020-11-202023-09-27R.P. Scherer Technologies, LLCGlycoside dual-cleavage linkers for antibody-drug conjugates
AU2022283289A1 (en)2021-05-272023-12-07R.P. Scherer Technologies, LlcMethods of controlling cleavage of formylglycine-containing polypeptides
EP4108669A1 (en)*2021-06-242022-12-28Institute Of Organic Chemistry And Biochemistry As CR, V.V.I.Carbohydrate derivatives and kits for cell surface labeling
US11879010B2 (en)2021-09-302024-01-23The Charlotte Mecklenburg Hospital AuthorityMethods and compositions for pretargeted immunotherapy
CN117736135B (en)*2024-02-192024-05-07西北农林科技大学深圳研究院 A method for site-specific modification of proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4321366A (en)*1978-05-121982-03-23Research CorporationProcess of preparing 2-azido-2-deoxyarabinofuranosyl halides
US4292437A (en)*1979-06-271981-09-29E. I. Du Pont De Nemours And CompanyPreparation of isobutyric acid and esters
CA1340899C (en)*1988-03-092000-02-15Andre BardyProcede de preparation de complexes nitruro 99m tc, 186 re ou 188 re utilisables comme produits radiopharmaceutiques
DE4325816A1 (en)*1993-07-311995-02-02Hoechst Ag Secondary and tertiary phosphines and process for their preparation
US5874628A (en)*1997-03-261999-02-23Monsanto CompanyMethod for preparation of tertiary phosphines via nickel-catalyzed cross coupling
US6570040B2 (en)*2000-03-162003-05-27The Regents Of The University Of CaliforniaChemoselective ligation
CA2405105C (en)2000-05-122011-07-26Wisconsin Alumni Research FoundationLigation method and reagents to form an amide bond

Also Published As

Publication numberPublication date
EP1263771A2 (en)2002-12-11
US20020016003A1 (en)2002-02-07
US20110236930A1 (en)2011-09-29
DE60120650T2 (en)2007-05-31
US20080214801A1 (en)2008-09-04
US8076496B2 (en)2011-12-13
US6570040B2 (en)2003-05-27
US20030199084A1 (en)2003-10-23
US7838665B2 (en)2010-11-23
US20050148032A1 (en)2005-07-07
EP1263771B1 (en)2006-06-14
WO2001068565A2 (en)2001-09-20
US7667012B2 (en)2010-02-23
DE60120650D1 (en)2006-07-27
WO2001068565A3 (en)2002-05-23
ATE329925T1 (en)2006-07-15
US7122703B2 (en)2006-10-17
US7939626B2 (en)2011-05-10
US7923582B2 (en)2011-04-12
US20070037964A1 (en)2007-02-15
US20060276658A1 (en)2006-12-07

Similar Documents

PublicationPublication DateTitle
AU2001281463A1 (en)Chemoselective ligation
WO2006050262A3 (en)Compositions and methods for modification of biomolecules
WO2007107587A3 (en)Cholesterol lowering protein hydrolysates
AU2001283343A1 (en)Adhesive compositions including self-assembling molecules, adhesives, articles, and methods
WO2004033488A3 (en)Peptide mediated synthesis of metallic and magnetic materials
EP1623994A3 (en)Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
WO2007008848A3 (en)Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
WO2007068906A3 (en)Production of conjugates
WO2002038592A3 (en)Peptides, the production and use thereof for binding immunoglobulins
AU2002342597A1 (en)Process for preparing insulin compounds
JP4342934B2 (en) Administration of drugs via PEPT-2 transporter
WO2001046213A3 (en)Compound comprising a peptide moiety and an organo-silane moiety.
WO2005039641A3 (en)Biomacromolecule polymer conjugates
WO2001087920A3 (en)Ligation method and reagents to form an amide bond
AU2002215904A1 (en)Compounds with a branched linker
SG170022A1 (en)Method for production of peptide thioester compound
EP1452543A3 (en)RGD (ARG-GLY-ASP) coupled to (neuro)peptides
US5871954A (en)Fatty acid analog enzyme substrates
WO2008067495A3 (en)Chemotherapeutic conjugates and methods of use
US11345910B2 (en)Modified mussel proteins, uses thereof and related compounds
FR2864534B1 (en) SYNTHESIS OF ACYLUREES AND COMPOSITION COMPRISING ACYLUREES
Singh et al.A novel heterobifunctional linker for facile access to bioconjugates
WO2003018523A1 (en)Process for producing optically active halopropanediol derivative
WO2024064752A3 (en)Compositions of wet adhesives derived from vibrio cholerae biofilm adhesins and methods thereof
WO2003027137A3 (en)Trimeric conjugates of peptidic derivative

[8]ページ先頭

©2009-2025 Movatter.jp